MHRA to roll out new AI sandbox for medicines development

The UK’s MHRA has announced plans to launch a new AI sandbox to expedite the development of medicines and improve safety. The new MHRA sandbox will allow innovators to test AI systems to enhance medicines’ safety and predict side effects. The MHRA intends to use findings from the sandbox to evaluate the reliability of AI tools for new medicines’ safety. Credit: Gorodenkoff / Shutterstock.com. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans to launch a new AI sandbox to expedite the development of medicines and improve safety. The programme will investigate the ways in which AI…

Source: Pharmaceutical Technology